Arian Afendy

4.7k total citations · 2 hit papers
33 papers, 3.3k citations indexed

About

Arian Afendy is a scholar working on Epidemiology, Hepatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Arian Afendy has authored 33 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 16 papers in Hepatology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Arian Afendy's work include Liver Disease Diagnosis and Treatment (25 papers), Hepatitis C virus research (8 papers) and Diet, Metabolism, and Disease (5 papers). Arian Afendy is often cited by papers focused on Liver Disease Diagnosis and Treatment (25 papers), Hepatitis C virus research (8 papers) and Diet, Metabolism, and Disease (5 papers). Arian Afendy collaborates with scholars based in United States, Australia and Philippines. Arian Afendy's co-authors include Zobair M. Younossi, Fatema Nader, Manirath Srishord, Pegah Golabi, Ying Qiu, Leyla de Avila, James M. Paik, Natsu Fukui, Leah Burns and Maria Stepanova and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Arian Afendy

33 papers receiving 3.3k citations

Hit Papers

The global epidemiology of NAFLD and NASH in patients wit... 2018 2026 2020 2023 2019 2018 500 1000 1.5k

Peers

Arian Afendy
Renata Belfort United States
Chantal A. Rivera United States
Hazem Elariny United States
Arian Afendy
Citations per year, relative to Arian Afendy Arian Afendy (= 1×) peers Luis Calzadilla Bertot

Countries citing papers authored by Arian Afendy

Since Specialization
Citations

This map shows the geographic impact of Arian Afendy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arian Afendy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arian Afendy more than expected).

Fields of papers citing papers by Arian Afendy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arian Afendy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arian Afendy. The network helps show where Arian Afendy may publish in the future.

Co-authorship network of co-authors of Arian Afendy

This figure shows the co-authorship network connecting the top 25 collaborators of Arian Afendy. A scholar is included among the top collaborators of Arian Afendy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arian Afendy. Arian Afendy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Younossi, Zobair M., Pegah Golabi, Leyla de Avila, et al.. (2019). The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. Journal of Hepatology. 71(4). 793–801. 1517 indexed citations breakdown →
2.
Younossi, Zobair M., Maria Stepanova, Janus P. Ong, et al.. (2018). Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clinical Gastroenterology and Hepatology. 17(4). 748–755.e3. 603 indexed citations breakdown →
3.
Younossi, Zobair M., Arian Afendy, Maria Stepanova, et al.. (2017). Development and validation of a primary sclerosing cholangitis–specific patient‐reported outcomes instrument. Hepatology. 68(1). 155–165. 29 indexed citations
4.
Page, Sandra, Aybike Birerdinc, Michael Estep, et al.. (2013). Knowledge-Based Identification of Soluble Biomarkers: Hepatic Fibrosis in NAFLD as an Example. PLoS ONE. 8(2). e56009–e56009. 12 indexed citations
5.
Baranova, Ancha, Arian Afendy, Lei Wang, et al.. (2013). Molecular signature of adipose tissue in patients with both Non-Alcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovarian Syndrome (PCOS). Journal of Translational Medicine. 11(1). 133–133. 71 indexed citations
6.
Younossi, Zobair M., et al.. (2012). The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin. Journal of Translational Medicine. 10(1). 25–25. 21 indexed citations
7.
Stepanova, Maria, Noreen Hossain, Arian Afendy, et al.. (2010). Hepatic Gene Expression of Caucasian and African-American Patients with Obesity-Related Non-Alcoholic Fatty Liver Disease. Obesity Surgery. 20(5). 640–650. 45 indexed citations
8.
Mehta, Rohini, Aybike Birerdinc, Noreen Hossain, et al.. (2010). Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples. BMC Molecular Biology. 11(1). 39–39. 95 indexed citations
9.
Younossi, Zobair M., Sandra Page, Nila Rafiq, et al.. (2010). A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis. Obesity Surgery. 21(4). 431–439. 126 indexed citations
10.
Hossain, Noreen, Maria Stepanova, Arian Afendy, et al.. (2010). Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS). Scandinavian Journal of Gastroenterology. 46(4). 479–484. 50 indexed citations
11.
Estep, Michael, Ancha Baranova, Noreen Hossain, et al.. (2009). Expression of Cytokine Signaling Genes in Morbidly Obese Patients with Non-Alcoholic Steatohepatitis and Hepatic Fibrosis. Obesity Surgery. 19(5). 617–624. 46 indexed citations
12.
Younossi, Zobair M., Ancha Baranova, Arian Afendy, et al.. (2009). Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon‐alfa and ribavirin†. Hepatology. 49(3). 763–774. 36 indexed citations
13.
Younossi, Zobair M., Arian Afendy, Maria Stepanova, et al.. (2009). Gene expression profile associated with superimposed non‐alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C. Liver International. 29(9). 1403–1412. 8 indexed citations
14.
Estep, Michael, Linda P. O’Reilly, Geraldine M. Grant, et al.. (2009). Hepatic Stellate Cell and Myofibroblast-Like Cell Gene Expression in the Explanted Cirrhotic Livers of Patients Undergoing Liver Transplantation. Digestive Diseases and Sciences. 55(2). 496–504. 4 indexed citations
15.
Hossain, Noreen, Arian Afendy, Maria Stepanova, et al.. (2009). Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 7(11). 1224–1229.e2. 275 indexed citations
16.
Kallman, Jillian, Arian Afendy, Maria Stepanova, et al.. (2009). T1039 Health-Related Quality of Life (HRQL) in Patients with Chronic Liver Diseases. Gastroenterology. 136(5). A–486. 1 indexed citations
17.
Mishra, Poonam, Clare Nugent, Arian Afendy, et al.. (2008). Apnoeic–hypopnoeic episodes during obstructive sleep apnoea are associated with histological nonalcoholic steatohepatitis. Liver International. 28(8). 1080–1086. 94 indexed citations
18.
Nugent, Clare, Chunhong Bai, Hazem Elariny, et al.. (2008). Metabolic Syndrome after Laparoscopic Bariatric Surgery. Obesity Surgery. 18(10). 1278–1286. 28 indexed citations
19.
Calvert, Valerie, Rochelle Collantes, Hazem Elariny, et al.. (2007). A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology. 46(1). 166–172. 42 indexed citations
20.
Baranova, Ancha, Karen Schlauch, Hazem Elariny, et al.. (2006). Gene Expression of Leptin, Resistin, and Adiponectin in the White Adipose Tissue of Obese Patients with Non-Alcoholic Fatty Liver Disease and Insulin Resistance. Obesity Surgery. 16(9). 1118–1125. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026